Home » Stocks » FMS

Fresenius Medical Care AG & Co. (FMS)

Stock Price: $35.03 USD -0.33 (-0.93%)
Updated Feb 25, 2021 4:00 PM EST - Market closed
After-hours: $34.68 -0.35 (-1.00%) Feb 25, 6:42 PM
Market Cap 20.66B
Revenue (ttm) 17.86B
Net Income (ttm) 1.16B
Shares Out 298.33M
EPS (ttm) 3.69
PE Ratio 9.49
Forward PE 13.40
Dividend $1.24
Dividend Yield 3.53%
Trading Day February 25
Last Price $35.03
Previous Close $35.36
Change ($) -0.33
Change (%) -0.93%
Day's Open 35.10
Day's Range 34.86 - 35.45
Day's Volume 327,188
52-Week Range 29.17 - 46.55

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
Zacks Investment Research - 1 day ago

Fresenius Medical's (FMS) fourth-quarter earnings benefit from strength in Health Care Products segment, and performance across EMEA and Asia Pacific.

Benzinga - 2 days ago

Shares of Fresenius Medical Care (NYSE:FMS) rose 0.0% after the company reported Q4 results. Quarterly Results Earnings per share fell 50.00% year over year to $0.76, which missed the estimate...

Zacks Investment Research - 1 month ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 1 month ago

Here are some dirt-cheap MedTech value stocks which are expected to provide long-term gains in 2021.

Other stocks mentioned: DGX, HSIC, IVC
PRNewsWire - 1 month ago

WALTHAM, Mass., Jan. 11, 2021 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for people with chronic kidney failure, announced today that the com...

Seeking Alpha - 1 month ago

Fresenius Medical Care might not be a ten-bagger in the next few years. Conversely, the stock currently offers a very good risk/reward ratio.

Zacks Investment Research - 1 month ago

Fresenius (FMS) is well positioned to outperform the market, as it exhibits above-average growth in financials.

Zacks Investment Research - 1 month ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 2 months ago

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

Zacks Investment Research - 2 months ago

Is Fresenius Medical Care (FMS) a great pick from the value investor's perspective right now? Read on to know more.

GuruFocus - 2 months ago

David Herro (Trades, Portfolio), a portfolio manager of the Oakmark International Fund, disclosed this week that the fund's top four trades during the third quarter included new positions in F...

Other stocks mentioned: BUD, DMLRY
Seeking Alpha - 2 months ago

The German Dividend Aristocrats (GDA) have been updated - this is the 2020 version. There are 53 (-1) identified Dividend Aristocrats in Germany as of November 2020.

Other stocks mentioned: FUPBY
Zacks Investment Research - 3 months ago

Fresenius Medical's (FMS) third-quarter earnings benefit from stable segmental performance.

Seeking Alpha - 3 months ago

Despite the correction, stocks - especially US stocks - are still trading at very high multiples and it is difficult to find bargains. Bayer and Fresenius are two German large-cap stocks that ...

Other stocks mentioned: BAYRY, CVS, MMM
Seeking Alpha - 3 months ago

Fresenius Medical Care AG & Co. KGaA (FMS) CEO Robert Powell on Q3 2020 Results - Earnings Call Transcript

Seeking Alpha - 3 months ago

Fresenius delivered very solid results despite the pandemic. Importantly, all guidance was confirmed.

Seeking Alpha - 4 months ago

Fresenius Medical Care's Unexciting Capital Markets Day

Zacks Investment Research - 4 months ago

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services. However, intense competition remains a woe.

Zacks Investment Research - 5 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 5 months ago

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
Zacks Investment Research - 5 months ago

Let's grab these three stocks that have continued to show tremendous promise despite market volatility resulting from the coronavirus pandemic.

Other stocks mentioned: HOLX, TMO
Business Wire - 5 months ago

Fresenius Medical Care Asia Pacific responds to call for education in preparation of ultrapure dialysis fluid in developing economies

Zacks Investment Research - 5 months ago

While searching for a suitable value investment option, investors are unlikely to consider PEG ratio among a number of other popular value metrics.

Other stocks mentioned: HBI, RBC, WHR
Zacks Investment Research - 5 months ago

Here are some dirt-cheap MedTech value stocks which have been battered by the pandemic-led market meltdown and can be considered for long-term gains.

Other stocks mentioned: AMN, DVA, NXGN
Zacks Investment Research - 5 months ago

Let's grab these three stocks that have shown tremendous promise amid the coronavirus pandemic.

Other stocks mentioned: OMI, TMO
Zacks Investment Research - 5 months ago

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
Zacks Investment Research - 5 months ago

Here are some MedTech growth stocks which might be solid investment options for profit-maximization amid the coronavirus-led market mayhem.

Other stocks mentioned: ELMD, NXGN, TVTY
Zacks Investment Research - 5 months ago

There are some drawbacks to using the PEG ratio though. It does not consider the very common situation of changing growth rates.

Other stocks mentioned: ALL, PHM, RBC, URI
Zacks Investment Research - 6 months ago

Fresenius Medical (FMS) continues to gain traction from its broad range of dialysis products and services.

Zacks Investment Research - 6 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 6 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Seeking Alpha - 6 months ago

Fresenius Medical Care is the largest dialysis provider in the world.

Zacks Investment Research - 6 months ago

Fresenius (FMS) could produce exceptional returns because of its solid growth attributes.

Zacks Investment Research - 6 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 6 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Zacks Investment Research - 6 months ago

FMS vs. SMLR: Which Stock Is the Better Value Option?

Other stocks mentioned: SMLR
Zacks Investment Research - 6 months ago

Even though profit is a company's goal, cash is its lifeblood for existence and a measure of resiliency.

Other stocks mentioned: GFF, SMFKY, TPB
Zacks Investment Research - 6 months ago

Fresenius Medical's (FMS) second-quarter earnings benefit from strong segmental performance.

Zacks Investment Research - 6 months ago

Fresenius (FMS) could produce exceptional returns because of its solid growth attributes.

Seeking Alpha - 6 months ago

Fresenius SE & Co. KGaA (FSNUF) Management on Q2 2020 Results - Earnings Call Transcript

Seeking Alpha - 6 months ago

Fresenius Medical Care AG & Co. KGaA (FMS) CEO Robert Powell on Q2 2020 Results - Earnings Call Transcript

CNBC International TV - 6 months ago

Fresenius CFO: Business model strong despite pandemic's challenges

Fresenius CFO Rachel Empey discusses the impact of the coronavirus pandemic on the health-care company's second-quarter earnings.

Business Wire - 7 months ago

LAKE ZURICH, Ill.--(BUSINESS WIRE)--The date under the "Expiration Date" column for the row associated with Batch Number 6122207 should read: 06/2021 (instead of 06/2020).

Business Wire - 7 months ago

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi USA is voluntarily recalling two lots of Dexmedetomidine HCl in 0.9% Sodium Chloride Injection, 200 mcg/50 mL (4 mcg / mL), 50 mL fill in a 5...

Zacks Investment Research - 7 months ago

FMS vs. ABMD: Which Stock Is the Better Value Option?

Other stocks mentioned: ABMD
Zacks Investment Research - 7 months ago

Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to th...

Seeking Alpha - 7 months ago

Kiplinger Investing, offering "insights for investors" online, compiled a "Worlds Most Reliable" list of 99 in October, 2018. Data updated 6/25/20 showed 19 whose yields signaled a time to buy.

Other stocks mentioned: BCE, BNS, BTI, CM, CNQ, CVX, ED, ENB, LRLCY, MFGP, PRU, RY, SU, T, WPP, XOM
The Motley Fool - 7 months ago

These companies are all surprising a few doubters lately.

Other stocks mentioned: ARNA, CARA
The Motley Fool - 9 months ago

MSA Safety, Fresnius Medical Care, and LeMaitre Vascular are well-priced stocks on the rise with solid dividends.

Other stocks mentioned: MDT, LMAT, MSA
Zacks Investment Research - 9 months ago

Fresenius Medical's (FMS) first-quarter earnings benefit from strong segmental performance.

About FMS

Fresenius Medical Care AG & KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services in Germany, the United States, and internationally. It offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the Uni... [Read more...]

Industry
Medical Care Facilities
IPO Date
Sep 19, 1996
CEO
Rice Powell
Employees
125,364
Stock Exchange
NYSE
Ticker Symbol
FMS
Full Company Profile

Financial Performance

In 2020, FMS's revenue was $17.86 billion, an increase of 2.19% compared to the previous year's $17.48 billion. Earnings were $1.16 billion, a decrease of -2.94%.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for FMS stock is "Buy." The 12-month stock price forecast is 37.57, which is an increase of 7.25% from the latest price.

Price Target
$37.57
(7.25% upside)
Analyst Consensus: Buy